CME’s new swap future uses Goldman Sachs patent

A businessman with a light-bulb head representing an idea

CME Group's planned new swap futures product is based on a patent owned by and licensed from Goldman Sachs – a deal some market participants see as an attempt by the investment bank to hedge its bets, as over-the-counter products face a tougher regulatory regime.

Goldman Sachs is one of four dealer market-makers for the product, which was announced by CME on September 18. The others are Citi, Credit Suisse and Morgan Stanley. The exchange could be paying Goldman Sachs as much as 15–20% of the re

To continue reading...

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: